kabutan
N225

65,269.33

-1.70%

TOPIX

4,050.33

-1.83%

USDJPY

153.85

-0.34%

Kabutan Concierge Closed Beta - Apply now

Nxera Pharma to receive $8.6 million milestone from Centessa Pharmaceuticals

Thu Sep 3, 2026 4:10 pm JST Catalyst

Nxera Pharma Co., Ltd. <4565> announced after market close that it will receive an $8.6 million (about 1.38 billion yen) milestone payment from partner Centessa Pharmaceuticals, a subsidiary of Eli Lilly , following late-stage R&D progress on a selective orexin 2 receptor (OX2R) agonist. The milestone will be recognized in full as revenue in the third quarter of the fiscal year ending December 2026. Nxera said the impact on its full-year earnings forecast is already incorporated into guidance.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.